Cellid, COVID-19 vaccine Korean stock

Zaktualizowano
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Zlecenie aktywne
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
Zlecenie aktywne
Space elevator~
Transakcja zakończona: osiągnięto poziom stop
Events didn't pan out as I had expected.

Too bad.
Technical IndicatorsTrend Analysis

Również na:

Wyłączenie odpowiedzialności